IL134165A0 - Analgesic compositions comprising anti-epileptic compounds and methods of using same - Google Patents

Analgesic compositions comprising anti-epileptic compounds and methods of using same

Info

Publication number
IL134165A0
IL134165A0 IL13416598A IL13416598A IL134165A0 IL 134165 A0 IL134165 A0 IL 134165A0 IL 13416598 A IL13416598 A IL 13416598A IL 13416598 A IL13416598 A IL 13416598A IL 134165 A0 IL134165 A0 IL 134165A0
Authority
IL
Israel
Prior art keywords
methods
pain
same
compounds
novel combinations
Prior art date
Application number
IL13416598A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL134165A0 publication Critical patent/IL134165A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13416598A 1997-09-08 1998-08-18 Analgesic compositions comprising anti-epileptic compounds and methods of using same IL134165A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5820797P 1997-09-08 1997-09-08
PCT/US1998/017083 WO1999012537A1 (fr) 1997-09-08 1998-08-18 Compositions analgesiques comprenant des composes anticonvulsivants et leur mode d'utilisation

Publications (1)

Publication Number Publication Date
IL134165A0 true IL134165A0 (en) 2001-04-30

Family

ID=22015361

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13416598A IL134165A0 (en) 1997-09-08 1998-08-18 Analgesic compositions comprising anti-epileptic compounds and methods of using same
IL185345A IL185345A0 (en) 1997-09-08 2007-08-16 Analgesic compositions comprising anti-epileptic compounds and methods of using same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL185345A IL185345A0 (en) 1997-09-08 2007-08-16 Analgesic compositions comprising anti-epileptic compounds and methods of using same

Country Status (20)

Country Link
US (3) US6593368B2 (fr)
EP (1) EP1011658B1 (fr)
JP (1) JP3782935B2 (fr)
KR (1) KR100537707B1 (fr)
AT (1) ATE311867T1 (fr)
AU (1) AU750578B2 (fr)
BR (1) BR9812162A (fr)
CA (1) CA2296336C (fr)
CU (1) CU23226B7 (fr)
DE (1) DE69832712T2 (fr)
DK (1) DK1011658T3 (fr)
ES (1) ES2253825T3 (fr)
HU (1) HU226165B1 (fr)
IL (2) IL134165A0 (fr)
IS (1) IS5362A (fr)
NO (1) NO324122B1 (fr)
NZ (1) NZ502671A (fr)
PL (1) PL339142A1 (fr)
WO (1) WO1999012537A1 (fr)
ZA (1) ZA988159B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9710536A (pt) 1996-07-24 1999-08-17 Warner Lambert Co Isobutilgaba e seus derivados para o tratamento da dor
IL134165A0 (en) 1997-09-08 2001-04-30 Warner Lambert Co Analgesic compositions comprising anti-epileptic compounds and methods of using same
ID28277A (id) 1998-07-09 2001-05-10 Warner Lambert Co Komposisi-komposisi yang terdiri dari analog-analog gaba dan kaffein
AU3216600A (en) * 1999-03-10 2000-09-28 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
AU4334900A (en) 1999-04-09 2000-11-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
WO2001000191A2 (fr) * 1999-06-23 2001-01-04 Warner-Lambert Company Utilisation de fosphenytoine pour le traitement de douleur neuropathique aigue
ATE284223T1 (de) * 1999-08-20 2004-12-15 Ortho Mcneil Pharm Inc Zusammensetzung enthaltend ein tramadol und ein antikonvulsives arzneimittel
ES2253579T3 (es) 2001-09-03 2006-06-01 Newron Pharmaceuticals S.P.A. Composicion farmaceutica que comprende gabapentina o un analogo suyo y una alfa-aminoamida y su uso analgesico.
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
TWI312285B (en) * 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US20070184104A1 (en) * 2001-10-25 2007-08-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
US6730667B2 (en) * 2001-11-26 2004-05-04 William R. Deagle Iontophoresis disc pain blocker
JP4428053B2 (ja) 2002-02-05 2010-03-10 味の素株式会社 ガバペンチン若しくはプレガバリンおよびｎ型カルシウムチャンネル拮抗剤を含有する医薬組成物
CA2476438A1 (fr) * 2002-02-22 2003-08-28 Warner-Lambert Company Llc Combinaisons d'un ligand alpha-2-delta avec un inhibiteur selectif de cyclooxygenase-2
KR20070091049A (ko) * 2002-12-13 2007-09-06 워너-램버트 캄파니 엘엘씨 하부요로증상을 치료하기 위한 알파-2-델타 리간드
FR2862875B1 (fr) * 2003-12-02 2006-04-07 Mathey Acoustique Service Preparation pharmaceutique pour le traitement des acouphenes
CN101080224B (zh) * 2004-11-16 2011-03-30 利默里克神经科学股份有限公司 治疗疼痛的组合物及其应用
US20070087977A1 (en) * 2004-11-16 2007-04-19 Wendye Robbins Methods and compositions for treating pain
KR20080034205A (ko) * 2005-09-19 2008-04-18 테바 파마슈티컬 인더스트리즈 리미티드 (ｓ)-프레가발린의 신규한 합성을 위한 주요 중간체인 키랄3-카르바모일메틸-5-메틸 헥산산
MXPA05011735A (es) * 2005-11-01 2007-04-30 Leopoldo Espinosa Abdala Composiciones farmaceuticas que comprenden combinaciones de analgesicos y anticonvulsivantes para el tratamiento del dolor agudo y cronico.
US20090176882A1 (en) * 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
UA94979C2 (uk) * 2006-12-22 2011-06-25 Рекордати Айеленд Лимитед КОМБІНОВАНА ТЕРАПІЯ ПОРУШЕНЬ НИЖНІХ СЕЧОВИВІДНИХ ШЛЯХІВ ЛІГАНДАМИ α2δ І НПЗП
MX2007006091A (es) * 2007-05-21 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsionante.
JP5592790B2 (ja) * 2007-08-06 2014-09-17 トリニティ ラボラトリーズ インコーポレイテッド 慢性疼痛およびニューロパシーに関連する疼痛を治療する医薬組成物
SG157299A1 (en) 2008-05-09 2009-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
EP2297090A1 (fr) * 2008-06-23 2011-03-23 Teva Pharmaceutical Industries Ltd. Synthèse enzymatique stéréosélective de l ester (s) ou (r)-isobutylglutarique
FR2934267B1 (fr) * 2008-07-23 2010-08-13 Pharmaleads Derives aminophosphiniques utiles dans le traitement de la douleur
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
CA2738468A1 (fr) 2008-09-27 2010-04-01 Taraxos Inc. Formulations topiques pour le traitement d'une neuropathie
KR101810246B1 (ko) 2008-10-08 2017-12-18 엑스진 파마슈티컬 인크. Ｇａｂａ 접합체 및 그의 사용 방법
PL2599487T3 (pl) * 2010-07-30 2015-09-30 Toray Industries Środek terapeutyczny lub środek profilaktyczny przeciwko bólowi neuropatycznemu
WO2013076339A1 (fr) * 2011-11-22 2013-05-30 Servicio Andaluz De Salud Compositions et préparations combinées pour le traitement de la fibromyalgie
US9545415B2 (en) * 2012-01-06 2017-01-17 Skyview Enterprise Ltd. Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation
FR2998892B1 (fr) 2012-12-04 2015-01-02 Pf Medicament Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments
MX2015016589A (es) 2015-12-02 2017-06-01 Samuel CHAIT AUERBACH Jaime Composicion oral veterinaria con gabapentina.
KR102631399B1 (ko) * 2018-03-30 2024-02-01 씨지인바이츠 주식회사 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
CA3079509C (fr) 2018-07-04 2020-11-03 AMEZCUA AMEZCUA, Federico Combinaison medicamenteuse synergique de l'enantiomere actif (s)-ketorolac et de gabapentine pour le traitement de la douleur neuropathique
MX2019008467A (es) * 2019-07-16 2019-11-07 Federico Amezcua Amezcua Combinacion sinergica de s-ketorolaco y pregabalina en una composicion farmaceutica para el tratamiento del dolor neuropatico.
US11147780B2 (en) * 2020-02-24 2021-10-19 Algia Pharma, Llc Multidrug pain management package

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634102A (fr) *
DE1963925C3 (de) * 1969-12-20 1975-07-10 Desitin-Werk, Carl Klinke Gmbh, 2000 Hamburg Verfahren zur Herstellung von N hoch 3-Carbalkoxyderivaten des 5,5-Diphenylhydantoins
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS54110334A (en) * 1978-02-16 1979-08-29 Fuji Chem Ind Co Ltd Novel compounded anodyne and antiiinflammatory agent
JPS61221121A (ja) * 1985-03-27 1986-10-01 Nitto Electric Ind Co Ltd テ−プ製剤
US4694010A (en) * 1985-08-16 1987-09-15 New York University Anticonvulsant compositions and method
JPH02502546A (ja) * 1987-12-22 1990-08-16 ファーカニー、ジョン　ダブリュ 抗ひきつけ剤組成物および方法のためのデキストロルファン相乗的協力剤
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
GB9108362D0 (en) * 1991-04-18 1991-06-05 Radoslavov Alexander A pharmaceutical composition suitable for alleviation of headaches,migraine and other painful conditions
DE69330949T2 (de) 1992-05-20 2002-04-04 Univ Northwestern Gaba und l-glutaminsaüre analoga zur behandlung der epilepsie
US5234929A (en) * 1992-07-20 1993-08-10 William Chelen Method of treating motion sickness with anticonvulsants and antitussive agents
JPH06100468A (ja) * 1992-09-25 1994-04-12 Kibun Food Chemifa Co Ltd 徐放性組成物
US5321012A (en) 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
JPH06227969A (ja) * 1993-02-02 1994-08-16 Masayasu Sugihara 薬品の腸溶性改善方法およびそれにより得られた薬品組成物
US5420270A (en) 1993-10-07 1995-05-30 G. D. Searle & Co. Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5352638A (en) 1994-02-22 1994-10-04 Corning Incorporated Nickel aluminosilicate glass-ceramics
ES2211916T3 (es) 1994-09-02 2004-07-16 Virginia Commonwealth University Composicion para aliviar dolor, que contiene un analgesico no narcortico y un potenciador de analgesia.
CN1046199C (zh) * 1994-12-13 1999-11-10 凌吉安 复方消炎止痛霜剂
BR9710536A (pt) * 1996-07-24 1999-08-17 Warner Lambert Co Isobutilgaba e seus derivados para o tratamento da dor
DE69733081T2 (de) * 1996-08-23 2006-05-11 Endo Pharmaceuticals Inc. (n.d.Ges.d. Staates Delaware) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
US6057373A (en) 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
AU8668598A (en) 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
IL134165A0 (en) 1997-09-08 2001-04-30 Warner Lambert Co Analgesic compositions comprising anti-epileptic compounds and methods of using same
AU3216600A (en) 1999-03-10 2000-09-28 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
US20020115705A1 (en) 2002-08-22
EP1011658B1 (fr) 2005-12-07
AU9198798A (en) 1999-03-29
US20030176505A1 (en) 2003-09-18
ZA988159B (en) 1999-03-11
CA2296336A1 (fr) 1999-03-18
DE69832712T2 (de) 2006-06-22
CA2296336C (fr) 2004-04-20
JP3782935B2 (ja) 2006-06-07
AU750578B2 (en) 2002-07-25
KR20010023745A (ko) 2001-03-26
NO20001175L (no) 2000-03-07
ES2253825T3 (es) 2006-06-01
WO1999012537A1 (fr) 1999-03-18
HU226165B1 (en) 2008-05-28
ATE311867T1 (de) 2005-12-15
HUP0003705A2 (hu) 2001-04-28
BR9812162A (pt) 2000-07-18
PL339142A1 (en) 2000-12-04
EP1011658A1 (fr) 2000-06-28
US20030065028A1 (en) 2003-04-03
HUP0003705A3 (en) 2002-01-28
JP2001515859A (ja) 2001-09-25
US6593368B2 (en) 2003-07-15
NO324122B1 (no) 2007-08-27
KR100537707B1 (ko) 2005-12-20
NZ502671A (en) 2003-01-31
DE69832712D1 (de) 2006-01-12
US6942876B2 (en) 2005-09-13
IS5362A (is) 2000-01-25
NO20001175D0 (no) 2000-03-07
IL185345A0 (en) 2008-01-06
CU23226B7 (es) 2007-09-26
DK1011658T3 (da) 2006-04-03

Similar Documents

Publication Publication Date Title
IL185345A0 (en) Analgesic compositions comprising anti-epileptic compounds and methods of using same
WO2001091736A3 (fr) Combinaisons d"un antagoniste de recepteur d"endotheline et compose anti-epileptique presentant des proprietes analgesiques ou de soulagement de la douleur
BR0008847A (pt) Composições analgésicas que compreendemcompostos antiepilépticos, e métodos de uso dasmesmas
AU4743601A (en) Neutral antagonists and use thereof in treating drug abuse
WO2002098370A3 (fr) Methodes d'administration/dosage d'antagonistes de cd2 pour la prevention et le traitement des maladies auto-immunes ou inflammatoires
BG105534A (en) 5ht1 means and method for the treatment of migraine
HK1023517A1 (en) Formulation of 5-ht agonists.
AUPN603895A0 (en) Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids
IL128723A0 (en) Pharmaceutical compositions containing rar antagonists and rxr agonists
WO2002026262A3 (fr) Procedes et compositions permettant de reduire les effets secondaires lies aux traitements de chimiotherapie
GEP20022784B (en) Celecoxib Composition
RU2002116361A (ru) Анальгезирующие композиции, содержащие бупренорфин
WO2002058620A3 (fr) Compositions pharmaceutiques contenant un inhibiteur de cox-ii et un relaxant musculaire
CA2302754A1 (fr) Noribogaine utilisee pour le traitement de la douleur et de la toxicomanie
CA2189916A1 (fr) Un nouveau regime pour l'administration de paclitaxel a des malades souffrant du sarcoma de kaposi
IL167890A (en) Use of a chorionic gonadotropin in the preparation of a medicament for treating a chronic pelvic pain syndrome
CA2509390A1 (fr) Methode de traitement du cancer de la prostate et composition pour son traitement
WO2001068125A3 (fr) Methodes et compositions de traitement et de prevention de la dyserection
ATE293451T1 (de) Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
IL140716A0 (en) Use of inhibitors of protein kinase c epsilon to treat pain
RU94045866A (ru) Применение бисфенилалкилпиперазинов для лечения расстройств, вызванных злоупотреблением веществами, способ лечения
PT1656131E (pt) Utilização de betaína para tratar claudicação intermitente
ATE240097T1 (de) Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
ECSP003378A (es) Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas